Cargando…
Thromboprophylaxis in primary shoulder arthroplasty does not seem to prevent death: a report from the Norwegian Arthroplasty Register 2005–2018
Background and purpose — There is still no consensus on whether to use thromboprophylaxis as a standard treatment in shoulder replacement surgery. We investigated the use of thromboprophylaxis reported to the Norwegian Arthroplasty Register (NAR). The primary endpoint was early mortality after prima...
Autores principales: | Hole, Randi M, Fenstad, Anne Marie, Gjertsen, Jan-Erik, Lie, Stein A, Furnes, Ove |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381958/ https://www.ncbi.nlm.nih.gov/pubmed/33821764 http://dx.doi.org/10.1080/17453674.2021.1906595 |
Ejemplares similares
-
Risk factors for revision after shoulder arthroplasty: 1,825 shoulder arthroplasties from the Norwegian Arthroplasty Register
por: Fevang, Bjørg-Tilde S, et al.
Publicado: (2009) -
Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group
por: Pedersen, Alma B, et al.
Publicado: (2019) -
Perioperative, short-, and long-term mortality related to fixation in primary total hip arthroplasty: a study on 79,557 patients in the Norwegian Arthroplasty Register
por: Dale, Håvard, et al.
Publicado: (2019) -
No difference in risk of revision due to infection between clindamycin and cephalosporins as antibiotic prophylaxis in cemented primary total knee replacements: a report from the Norwegian Arthroplasty Register 2005–2020
por: PAWLOY, Karola, et al.
Publicado: (2023) -
Association between duration of anticoagulant thromboprophylaxis and revision rate in primary total hip arthroplasty: a Danish and Norwegian nationwide cohort study
por: VINTHER, Dennis, et al.
Publicado: (2022)